The failure of nonvascular smooth muscle to relax in response to NO donors, despite cGMP elevation, may be due to a lack of PKG substrate phosphorylation, unlike in vascular smooth muscle.
Answers are grounded in this paper and cite their sources.
May underlie differential cGMP responses in vascular versus nonvascular smooth muscle; leaves open relevance to human physiology.
It is generally well accepted that nitrovasodilator-induced relaxation of vascular smooth muscle involves elevation of cGMP and activation of a specific cGMP-dependent protein kinase [protein kinase G (PKG)]. However, the protein targets of PKG and the underlying mechanisms by which this kinase leads to a relaxant response have not been elucidated. Several types of smooth muscle, including rat myometrium and vas deferens, are not relaxed by sodium nitroprusside, even at concentrations that produce marked elevation of cGMP and activation of PKG. The main objective of our studies was to compare PKG-mediated protein phosphorylation in intact rat aorta, rat myometrium, and rat vas deferens using two-dimensional gel electrophoresis. In intact rat aorta, seven PKG substrates were detected during relaxation of the tissue. None of the PKG substrates identified in the rat aorta appeared to be phosphorylated in the myometrium or vas deferens after administration of various cGMP-elevating agents. Thus the failure of the rat myometrium and rat vas deferens to relax in the face of cGMP elevation and PKG activation may be due to a lack of PKG substrate phosphorylation.
No takes yet. Share an insight, caveat, or question.
Hennan et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: